Nintedanib Capsules Approval and Launch

PARSIPPANY, N.J., April 7, 2026 /PRNewswire/ -- Dexcel Pharma USA is pleased to announce that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nintedanib Capsules, 100 mg and 150 mg, the generic equivalent...